Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 31, 2017 – The FDA approved an update to the Warnings and Precautions section of the Aranesp (darbepoetin alfa) drug label regarding severe cutaneous reactions.
Return to publications